Please assess the completion status of the following clinical trial:

Trial Title: Acute Treatment of Migraine With e-TNS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* History of episodic or chronic migraine with or without aura meeting the diagnostic criteria listed in ICHD-III beta (2013) section 1, migraine, with the exception of ''complicated migraine'' (i.e., hemiplegic migraine, basilar-type migraine, ophthalmoplegic migraine, migrainous infarction)~* Having a migraine attack lasting at least 3 hours~* Migraine pain intensity stabilized for at least 1 hour~* Frontal, retro-, or peri- orbital headache.~Exclusion Criteria:~* Pregnant women~* Patients having received Botox treatment in the prior 4 months~* Patients having received supraorbital nerve blocks in the prior 4 months~* Diagnosis of other primary or secondary headache disorders, except of Medication Overuse Headache~* Patients with only temporal or occipital headache~* Patients using opioid medication~* Patients having taken abortive migraine medication in the prior 3 hours~* Allodynia: intolerance to supraorbital neurostimulation (allodynia) that makes the treatment not applicable (the patients will be excluded if they are unable to tolerate the first 5 minutes of neurostimulation).~* Implanted metal or electrical devices in the head~* Cardiac pacemaker or implanted or wearable defibrillator~* Patient having had a previous experience with Cefaly®

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Active device (Type: EXPERIMENTAL): 60 minutes of active external trigeminal nerve stimulation with a CEFALY Active device
- Sham device (Type: SHAM_COMPARATOR): 60 minutes of placebo external trigeminal nerve stimulation with a CEFALY Placebo device

Based on this trial design, predict the completion outcome and termination type (if applicable).